# Febuxostat

## Feburic 80mg

| TAH Drug Code      | [OFEB](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OFEB)                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Chronic hyperuricaemia where urate deposition had occurred including history or presence of tophus &/or gouty arthritis.                                                                                                                                                                                                                                                                                                          |
| Dosing             | Gout: Initial dose: 40mg QD. If the serum uric acid concentration is not lower than 6mg/dL after taking the medicine for 2 weeks, change to 80mg QD. Tumor lysis syndrome: Two days before the start of cytotoxic drug treatment, 80 mg QD for 7 days. According to the clinical response during chemotherapy, it can be extended to 9 days.                                                                                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Hypersensitivity. Concomitant use of azathioprine or mercaptopurine.                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Common: Rash (0.5-1.6%), Diarrhea (>1%), Nausea (1.1-1.3%), Arthralgia (0.7-1.1%) Serious: Myocardial infarction, Drug reaction with eosinophilia and systemic symptoms, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Abnormal liver function (4.6-6.6%), ALT/SGPT level raised (3%), Aspartate aminotransferase serum level above reference range (2%), Gout, acute, Myositis, Rhabdomyolysis, Cerebrovascular accident |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                            |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                      |

